| scholarly article | Q13442814 |
| P50 | author | Elisa Clark | Q90662826 |
| Sven Loebrich | Q91723112 | ||
| P2093 | author name string | Thomas Ryll | |
| Stefani Takahashi | |||
| Anna Brousseau | |||
| Kristina Ladd | |||
| Robert Herbst | |||
| Seth Kitchener | |||
| P2860 | cites work | Glycoprofiling effects of media additives on IgG produced by CHO cells in fed-batch bioreactors. | Q51741789 |
| Modulation of mAb quality attributes using microliter scale fed-batch cultures. | Q51749017 | ||
| The effect of the removal of sialic acid, galactose and total carbohydrate on the functional activity of Campath-1H | Q71108219 | ||
| Improvement of interferon-gamma sialylation in Chinese hamster ovary cell culture by feeding of N-acetylmannosamine | Q28140074 | ||
| Depletion of manganese within the secretory pathway inhibits O-linked glycosylation in mammalian cells | Q30420604 | ||
| Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity | Q30835165 | ||
| High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans | Q31004131 | ||
| Glycosylation of therapeutic proteins: an effective strategy to optimize efficacy | Q33586660 | ||
| Effect of altered CH2-associated carbohydrate structure on the functional properties and in vivo fate of chimeric mouse-human immunoglobulin G1. | Q36363690 | ||
| Increased serum clearance of oligomannose species present on a human IgG1 molecule | Q36402812 | ||
| Enhanced recombinant M-CSF production in CHO cells by glycerol addition: model and validation | Q36495607 | ||
| Optimisation of the cellular metabolism of glycosylation for recombinant proteins produced by Mammalian cell systems | Q37323542 | ||
| Optimal and consistent protein glycosylation in mammalian cell culture | Q37506963 | ||
| Recent advances in the understanding of biological implications and modulation methodologies of monoclonal antibody N-linked high mannose glycans | Q38224264 | ||
| Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types | Q38308978 | ||
| Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells. | Q38338731 | ||
| Antibody-dependent cytotoxicity mediated by natural killer cells is enhanced by castanospermine-induced alterations of IgG glycosylation | Q38342853 | ||
| Tailoring recombinant protein quality by rational media design | Q38416739 | ||
| N-Glycosylation Design and Control of Therapeutic Monoclonal Antibodies | Q38789301 | ||
| Screening and assessment of performance and molecule quality attributes of industrial cell lines across different fed-batch systems | Q38826159 | ||
| Impact of cell culture on recombinant monoclonal antibody product heterogeneity | Q38907094 | ||
| CHO cell line specific prediction and control of recombinant monoclonal antibody N-glycosylation | Q39143876 | ||
| Fucose content of monoclonal antibodies can be controlled by culture medium osmolality for high antibody-dependent cellular cytotoxicity | Q39484103 | ||
| Modulation of antibody galactosylation through feeding of uridine, manganese chloride, and galactose | Q39590627 | ||
| Characterizing the effect of multiple Fc glycan attributes on the effector functions and FcγRIIIa receptor binding activity of an IgG1 antibody | Q39782184 | ||
| Rapid production of recombinant human IgG With improved ADCC effector function in a transient expression system | Q39801809 | ||
| Enhanced production of monomeric interferon-beta by CHO cells through the control of culture conditions. | Q40420472 | ||
| The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity | Q40690773 | ||
| Biochemistry of growth inhibition by ammonium ions in mammalian cells | Q41460725 | ||
| Controllability analysis of protein glycosylation in CHO cells | Q41909859 | ||
| Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome | Q42321222 | ||
| An investigation of intracellular glycosylation activities in CHO cells: effects of nucleotide sugar precursor feeding | Q43053168 | ||
| Metabolic control of recombinant protein N-glycan processing in NS0 and CHO cells | Q43547015 | ||
| Metabolic control of recombinant monoclonal antibody N-glycosylation in GS-NS0 cells | Q43728275 | ||
| Effects of ammonia and glucosamine on the heterogeneity of erythropoietin glycoforms. | Q43873679 | ||
| Glycosylation by Chinese hamster ovary cells in dolichol phosphate-supplemented cultures | Q44145125 | ||
| The formation of lipid-linked oligosaccharides in Madin-Darby canine kidney cells. Changes in oligosaccharide profiles induced by glucosamine | Q44734419 | ||
| Identification of manipulated variables for a glycosylation control strategy | Q46978895 | ||
| Parallel experimental design and multivariate analysis provides efficient screening of cell culture media supplements to improve biosimilar product quality. | Q48236068 | ||
| Tuning a MAb glycan profile in cell culture: Supplementing N-acetylglucosamine to favour G0 glycans without compromising productivity and cell growth. | Q51714148 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 335-349 | |
| P577 | publication date | 2018-10-22 | |
| P1433 | published in | Monoclonal Antibodies | Q6714645 |
| P1476 | title | Comprehensive manipulation of glycosylation profiles across development scales | |
| P478 | volume | 11 |
| Q91808144 | Antibody Structure and Function: The Basis for Engineering Therapeutics | cites work | P2860 |
Search more.